Aim Immunotech Inc (AIM) Annual Balance Sheets

Annual · GAAP · USD millions
Access AIM quarterly Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Aim Immunotech Inc's financial structure and capital allocation.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent2.99
Marketable Securities, Current SH0.06
Cash & Short-term Investments2.00
Accounts receivable0.01
Other Receivables, Net, Current0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.24
Total Current Assets3.30
Equipment/Property/Plant Net0.07
Intangible Assets1.66
Other Assets, Noncurrent0.76
Debt Securities-
Operating Lease Right Of Use Asset0.38
Total Assets5.78
Liabilities
Accounts Payable, Current AC1.63
Accrued Liabilities, Current AC0.80
Notes Payable, Current NO3.55
Total Current Liabilities6.22
Long-term debt0.93
Total Long-term Debt0.93
Derivative Liability, Noncurrent DE8.24
Other liabilities, Noncurrent0.00
Operating Lease Liability Current0.25
Operating Lease Liability Noncurrent0.17
Redeemable Warrants-
Total Liabilities15.57
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock431.00
Retained Earnings / Accumulated Deficit-440.79
Other Equity0.00
Common Stockholder's Equity-9.78
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-9.78
Liabilities & Stockholder's Equity5.78
4 historic quarters locked

Sign in to unlock the full Aim Immunotech Inc balance sheet history.

About Aim Immunotech Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 27, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-013301

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License